CorMedix Competitors and Similar CompaniesClear all
CorMedix's competitors and similar companies include Veloxis Pharmaceuticals.
 CorMedix CorMedix is a pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the treatment of cardiac and kidney disease. |  Veloxis Pharmaceuticals Veloxis Pharmaceuticals is a biopharmaceutical company that identifies, develops, and commercializes products used in transplantation and adjacent therapies. | |
Founding Date | Founding Date 2006 | Founding Date 2002 |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations Berkeley Heights, US HQ | Locations København, DK HQ Cary, US Cary, US |
Employees | Employees 3036% increase | Employees 54 |
Financial | ||
Revenue (est.) | Revenue (est.) $311.7m (FY, 2025) | Revenue (est.) kr39.5m (FY, 2018) |
Cost of goods | Cost of goods $22.1m (FY, 2025) | Cost of goods kr7.9m (FY, 2018) |
Gross profit | Gross profit $275.7m (FY, 2025) | Gross profit kr31.6m (FY, 2018) |
Net income | Net income $163.1m (FY, 2025) | Net income (kr5.3m) (FY, 2018) |
Funding | ||
Total funding raised | Total funding raised $ 11.5m | Total funding raised $ 60m |
For sources of this data, please see the company profile
View Company Profiles
Veloxis Pharmaceuticals
HQ
København, DK
Veloxis Pharmaceuticals is a biopharmaceutical company that identifies, develops, and commercializes products used in transplantation and adjacent therapies.
View company